SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin makes debut in Dow Jones Best-in-Class Indices

19 May 2026 Evaluate

Lupin has been featured for the first time in the Dow Jones Best-in-Class (DJBIC) Indices, underscoring the company’s strong commitment to sustainable, responsible, and ethical business practices. The company has been listed in both the DJBIC World Index and the DJBIC Emerging Markets Index. 

The DJBIC World Index ranks top-performing companies globally by strong Environmental, Social, and Governance (ESG) performance, while the DJBIC Emerging Markets Index highlights sustainability leaders across emerging economies. The company was previously ranked among the top 1% globally in the S&P Global Corporate Sustainability Assessment (CSA) 2025, achieving an industry-leading score of 91/100. 

The DJBIC Indices recognize companies that demonstrate exceptional performance across key ESG parameters, based on leading S&P Global CSA scores. Inclusion in these prestigious indices reinforces the company’s credibility with global investors, strengthens its competitive positioning, and places the company among a distinguished group of global leaders recognized for best-in-class sustainability performance.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2330.50 3.00 (0.13%)
19-Jun-2026 10:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1830.25
Dr. Reddys Lab 1262.00
Cipla 1356.95
Zydus Lifesciences 1076.00
Lupin 2330.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: